UnknownNot Applicable

Inter-observer Reliability of the TRiP(Cast) Score in Patients With Trauma to a Lower Limb Requiring Immobilisation

France302 participantsStarted 2024-05-16

Plain-language summary

The aim of the study isto evaluate the inter-observer reliability of the assessment of venous thromboembolic risk using the TRiP(cast) score in patients presenting with trauma to a lower limb requiring immobilisation, and of the clinicians' assessment using the physician's implicit probability (gestalt) compared with the use of the TRiP(cast) score.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Consultation in one of the emergency departments participating in the study, * Isolated trauma to a lower limb, * Rigid immobilisation (plaster or resin) or semi-rigid immobilisation for an expected duration of at least 7 days, * Patient over 18 years of age, * Patient affiliated to or benefiting from a social security scheme, * Patients who have signed a prior informed consent form Exclusion Criteria: * Patient taking anticoagulant treatment at the time of the trauma, * Trauma requiring hospitalisation for more than 48 hours, * Pregnant, breast-feeding or parturient patients, * Patient deprived of liberty by judicial or administrative decision, * Patient under compulsory psychiatric care, * Patient under legal protection, * Patients unable to give their free and informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The primary aim is to assess the inter-observer reliability of venous thromboembolic risk assessment using the TRiP(cast) score in patients with lower limb trauma requiring immobilisation.

Timeframe: Day 0

Trial details

NCT IDNCT06416280

SponsorUniversity Hospital, Angers

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2025-05-20

Contact for this trial

Delphine DOUILLET

(0)241353637 Delphine.Douillet@chu-angers.fr

View on ClinicalTrials.gov More Venous Thromboembolism trials